Ipsen (IPN.PA)’s Fourth Quarter and Full Year 2012 Sales  
1/30/2013 6:09:59 AM

Regulatory News:

Ipsen (Euronext: IPN; ADR: IPSEY) reported today its sales for the fourth quarter and full year 2012.

Commenting on the full year 2012 sales performance, Marc de Garidel, Chairman and Chief Executive Officer of Ipsen said: “From the first year on, Ipsen’s drug sales performance illustrates the relevance of the Group’s strategy of focus, with specialty care up 11.3%1, growing internationally and at an accelerating pace.